Technology

We are a Toronto-based biotechnology startup developing next-generation reconstructive and cosmetic solutions for the treatment of soft-tissue defects. Our platform integrates novel biomaterial scaffolds with a patients’ own cells to create regenerative solutions that actively restore tissue structure, function, and aesthetic appearance rather than simply filling or masking defects.

By leveraging autologous cells and biomaterials designed to support vascularization, integration, and long-term tissue stability, our approach aims to reduce donor-site morbidity, procedural complexity, and long-term complications associated with current grafting and implant-based therapies. Our mission is to shift soft-tissue reconstruction from passive repair to true biological regeneration, improving outcomes for patients across reconstructive and cosmetic indications.